Structure Therapeutics Reports Third Quarter 2026 Financial Results

Structure Therapeutics Inc. reported cash, cash equivalents and short-term investments of $1.2 billion as of September 30, 2026, compared to $1.3 billion as of June 30, 2026. The company expects its current cash, cash equivalents and short-term investments to fund projected opera